79 related articles for article (PubMed ID: 29621664)
1. Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts.
Krzykawska-Serda M; Agha MS; Ho JC; Ware MJ; Law JJ; Newton JM; Nguyen L; Curley SA; Corr SJ
Transl Oncol; 2018 Jun; 11(3):664-671. PubMed ID: 29621664
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic Esophageal Cancers: Intraesophageal Hyperthermia-enhanced Direct Chemotherapy in Rats.
Shi Y; Zhang F; Bai Z; Wang J; Qiu L; Li Y; Meng Y; Valji K; Yang X
Radiology; 2017 Jan; 282(1):103-112. PubMed ID: 27404050
[TBL] [Abstract][Full Text] [Related]
3. Local Magnetic Hyperthermia and Systemic Gemcitabine/Paclitaxel Chemotherapy Triggers Neo-Angiogenesis in Orthotopic Pancreatic Tumors without Involvement of Auto/Paracrine Tumor Cell VEGF Signaling and Hypoxia.
Maduabuchi WO; Tansi FL; Faenger B; Southern P; Pankhurst QA; Steiniger F; Westermann M; Hilger I
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201461
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer.
Bai Z; Shi Y; Wang J; Qiu L; Monroe EJ; Teng G; Zhang F; Yang X
Oncotarget; 2017 Jan; 8(2):3591-3599. PubMed ID: 27690303
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer.
Awasthi N; Monahan S; Stefaniak A; Schwarz MA; Schwarz RE
Oncotarget; 2018 Jan; 9(4):5274-5286. PubMed ID: 29435178
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant nab-paclitaxel plus gemcitabine
Yin ZZ; Zhao ZM; Tang WB; Jiang N; Zhang KD; Song YY; Wang Y; Li CG; Gao YX; Liu R
World J Clin Cases; 2020 Jul; 8(13):2778-2786. PubMed ID: 32742988
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound Doppler as an Imaging Modality for Selection of Murine 4T1 Breast Tumors for Combination Radiofrequency Hyperthermia and Chemotherapy.
Krzykawska-Serda M; Ho JC; Ware MJ; Law JJ; Newton JM; Nguyen L; Agha M; Curley SA; Corr SJ
Transl Oncol; 2018 Aug; 11(4):864-872. PubMed ID: 29763773
[TBL] [Abstract][Full Text] [Related]
8. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
9. The effects of non-invasive radiofrequency electric field hyperthermia on biotransport and biodistribution of fluorescent [60]fullerene derivative in a murine orthotopic model of breast adenocarcinoma.
Lapin NA; Krzykawska-Serda M; Dilliard S; Mackeyev Y; Serda M; Wilson LJ; Curley SA; Corr SJ
J Control Release; 2017 Aug; 260():92-99. PubMed ID: 28527736
[TBL] [Abstract][Full Text] [Related]
10. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
11. Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model.
Ware MJ; Krzykawska-Serda M; Chak-Shing Ho J; Newton J; Suki S; Law J; Nguyen L; Keshishian V; Serda M; Taylor K; Curley SA; Corr SJ
Sci Rep; 2017 Mar; 7():43961. PubMed ID: 28287120
[TBL] [Abstract][Full Text] [Related]
12. Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy.
Brunetti O; Badalamenti G; De Summa S; Calabrese A; Argentiero A; Fucci L; Longo V; Galetta D; Perrotti PMS; Pinto R; Petriella D; Danza K; Tommasi S; Leonetti F; Silvestris N
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31146476
[TBL] [Abstract][Full Text] [Related]
13. Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.
Javed MA; Beyer G; Le N; Vinci A; Wong H; Palmer D; Morgan RD; Lamarca A; Hubner RA; Valle JW; Alam S; Chowdhury S; Ma YT; Archibugi L; Capurso G; Maisonneuve P; Neesse A; Sund M; Schober M; Krug S
Pancreatology; 2019 Jan; 19(1):97-104. PubMed ID: 30529068
[TBL] [Abstract][Full Text] [Related]
14. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.
Veenstra VL; Damhofer H; Waasdorp C; van Rijssen LB; van de Vijver MJ; Dijk F; Wilmink HW; Besselink MG; Busch OR; Chang DK; Bailey PJ; Biankin AV; Kocher HM; Medema JP; Li JS; Jiang R; Pierce DW; van Laarhoven HWM; Bijlsma MF
Oncogenesis; 2018 Nov; 7(11):87. PubMed ID: 30442938
[TBL] [Abstract][Full Text] [Related]
15. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
Al Haddad AH; Adrian TE
Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
[TBL] [Abstract][Full Text] [Related]
16. Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma.
Neuzillet C; Babai S; Kempf E; Pujol G; Rousseau B; Le-Louët H; Christophe Tournigand
Medicine (Baltimore); 2016 Jun; 95(26):e4006. PubMed ID: 27368013
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab-paclitaxel chemotherapy: A case report.
Yokota T; Takano S; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Nojima H; Mishima T; Nakadai E; Ohtsuka M
Mol Clin Oncol; 2019 Apr; 10(4):419-424. PubMed ID: 30931110
[TBL] [Abstract][Full Text] [Related]
18. Perspectives in the treatment of pancreatic adenocarcinoma.
Cid-Arregui A; Juarez V
World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
[TBL] [Abstract][Full Text] [Related]
19. N1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2.
Yao M; Hong Y; Liu Y; Chen W; Wang W
Exp Ther Med; 2017 Sep; 14(3):2101-2107. PubMed ID: 28962130
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Treatment in Pancreatic Cancer.
Oba A; Ho F; Bao QR; Al-Musawi MH; Schulick RD; Del Chiaro M
Front Oncol; 2020; 10():245. PubMed ID: 32185128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
